Hansa Biopharma AB (publ) (FRA:24H)
3.042
+0.260 (9.35%)
At close: Dec 5, 2025
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
€121,471
Profits / Employee
€436,026
Market Cap
310.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Hansa Biopharma AB News
- 23 days ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases Transcript - Seeking Alpha
- 24 days ago - Hansa Biopharma AB (publ) (HNSBF) Discusses Phase III Trial Data and Developments in IgG-Cleaving Platform for Kidney Transplantation and Autoimmune Diseases - Slideshow - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Hansa Biopharma AB (HNSBF) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue ... - GuruFocus
- 5 weeks ago - Q3 2025 Hansa Biopharma AB Earnings Call Transcript - GuruFocus
- 5 weeks ago - Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results - PRNewsWire
- 5 weeks ago - Hansa hosts call with distinguished transplant surgeons: Insights on clinical practice and imlifidase Phase 3 Results - PRNewsWire